Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
Close
- 作为毕马威中国金融行业主管合伙人、资产管理行业主管合伙人和私募股权行业联席主管合伙人，吴先生为私募股权基金、主权基金及国企客户提供过众多里程碑项目的尽调服务。
- Louis与其客户就毕马威如何在提供更严谨有针对性的尽调工作及价值创造保持持续动态交流，并持续关注科技、关税和ESG等关键因素的影响，以帮助我们的客户在投资环境得到更多的保护和增值
- 同时，Louis在2006年赴华任职之前，曾就职于毕马威新加坡及伦敦分公司，对经济环境及地缘政治对金融行业的影响、全球PE行业动态、及中外金融环境具备一定专业积累。在就职专业领域广泛联络相关国内外交易咨询行业专业人士、客户、同事及潜在投资者，对中外PE行业交流具有积极的推动作用
Mr. Huang is Head of Cross-Border Investment / M&A and Co-Head of Global Consumer at FountainVest Partners. He joined FountainVest in 2017.
Mr. Huang sits on the boards of Amer Sports, Ziwi, Windrose Technology, and CFB Group. He previously sat on boards of Precor, Suunto and Trendy International. Prior to joining FountainVest, Mr. Huang spent 13 years with Goldman Sachs based in Hong Kong and New York, including as a Managing Director in the Mergers & Acquisitions Group and Head of China M&A.
Mr. Huang holds an MBA in Finance from the Wharton School and a Bachelor of Arts in Economics and Political Science from Columbia University.
Dr. Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia to lead investments and partnerships across the region, focusing primarily on the markets in China, Southeast Asia and India.
Dr. Kakar has more than 25 years of healthcare experience with several senior management roles across the globe and having worked in India, China, Singapore, Denmark and the USA. His previous roles include Head of M&A and Business Development at Everlife Asia, Head of Healthcare Investments for Asia with the Avenue Capital Group, and various senior leadership positions with GE Healthcare.
Dr. Kakar is a Medical Doctor with a postgraduate degree in Radiation and Nuclear Medicine from Tata Memorial Hospital and Cancer Centre in Mumbai, India.
Helen Wong is a Managing Partner at AC Ventures (ACV), an early-stage, Indonesia- focused technology venture capital fund. ACV manages five funds with an AUM of over US$500M and a portfolio of more than 120 businesses invested in the past eight years. The firm has led investments into Stockbit, Xendit, Shipper, Carsome and more.
Forbes magazine ranked her among China’s “Top 25 female VCs” and “Top 100 investors”. Forbes also ranked her as one of three Singaporeans among the Top “50 over 50” in Asia Pacific in 2024. Helen is a venture capitalist with a strong track record (over 20 years of experience), as she was part of the founding team at GGV Capital, and served as a Partner at Qiming Ventures.
Helen started her career in Silicon Valley/US, then moved to China, and now covers Southeast Asia. She led investments in Akulaku (a fintech unicorn) and Simplus in SE Asia, and has served the boards of highprofile Chinese internet companies. She has had 10 exits (7 IPOs and 3 M&As) among her portfolio companies including Tudou and QuantaSing on NASDAQ, Buchang on the Shanghai stock exchange, and Mobike (acquired by Meituan).
Helen graduated with a B.A. degree from Oxford University and a M.B.A. from INSEAD. She also has an E.M.B.A. degree from Cheung Kong Graduate School of Business in China. She is a Kauffman Fellow, and also participated in the China European International Business School (“CEIBS”) venture capital program.
David Selvia is a Partner at The Cathay Capital Group (CCG), a multi-bb series of China-focused growth equity funds. From the early 90s Cathay’s funds have led investments into 50+ businesses with exits by way of MNC trade sales, and A Share, HKSE, NYSE & Nasdaq IPOs.
David has 25+ years of investment experience in Asia. From 2000-2004 David led M&A/BD for various General Electric industrial business units, before then spearheading GE Capital’s China market entry. During his time at GE David was involved in dozens of new investments, JVs, partnerships as well as distressed workouts. Joining Cathay in 2006 in Hong Kong David went on to establish CCG’s Shanghai office before relocating to lead its Beijing operations. Currently David is responsible for new investments as well as cross-border initiatives.
David holds a BA from Boston University, an MBA from UPenn’s Wharton School and an MA from UPenn’s Lauder Institute. He has served on dozens of boards, both public and private. David is based in Shanghai, and speaks Mandarin.